Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Human BioSystems Awarded Organ Preservation Patent.
- M2 PRESSWIRE-31 March 2006-SessionsIR.com: Human BioSystems Awarded Organ Preservation PatentC1994-2006 M2 COMMUNICATIONS LTD RDATE:31032006 Stocks in the News: Dermisonics, Inc. (OTC: DMSI), Lexington Resources, Inc. (OTC: LXRS), Smart-tek Solutions Inc. (OTC: STTK), Human BioSystems Inc. (OTC: HBSC), Amgen Inc. (NASDAQ: AMGN),...
- Research articles 2006-03-31
- Abgenix (ABGX) SqueezeTrigger Price Is $8.94. Short Sellers Down Nearly $35 Million After Favorable Cancer Drug Phase III Results.
- M2 PRESSWIRE-3 November 2005-BUYINS.NET: Abgenix ABGX SqueezeTrigger Price Is $8.94. Short Sellers Down Nearly $35 Million After Favorable Cancer Drug Phase III ResultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:03112005 www.buyins.net, announced today that the 8.52 million shares declared short on Abgenix, Inc....
- Research articles 2005-11-03
- Abgenix (ABGX) SqueezeTrigger Price Is $8.94. Short Sellers Down Approximately $13 Million As Market Anticipates Colon Cancer Drug Results.
- M2 PRESSWIRE-20 October 2005-BUYINS.NET: Abgenix ABGX SqueezeTrigger Price Is $8.94. Short Sellers Down Approximately $13 Million As Market Anticipates Colon Cancer Drug Results.C1994-2005 M2 COMMUNICATIONS LTD RDATE:20102005 BUYINS.NET, www.buyins.net, announced today that the 8.38 million shares declared short on Abgenix,...
- Research articles 2005-10-20
- "Stocks on the Rise".
- M2 PRESSWIRE-15 June 2005-WallStreetGrapevine: "Stocks on the Rise"C1994-2005 M2 COMMUNICATIONS LTD RDATE:15062005 Wall Street, NYC - Today, wallstreetgrapevine.com, named; FacePrint Global Solutions, Inc. (OTC BB: FCPG), Aastrom Biosciences, Inc. (Nasdaq SC: ASTM), Millennium Pharmaceuticals, Inc. (Nasdaq NM: MLNM), and Abgenix...
- Research articles 2005-06-15
- Stocks on the Rise.
- M2 PRESSWIRE-11 May 2005-WallStreetGrapevine: Stocks on the RiseC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 Wall Street, NYC-Today, wallstreetgrapevine.com, named; Bio Matrix Scientific Group Inc. (Pink Sheets: BMXG), Miv Therapeutics Inc. (OTC BB: MIVT), BioSource International Inc. (Nasdaq NM: BIOI), and Abgenix Inc....
- Research articles 2005-05-11
- Stock Watch: (NASDAQ: VRSN) VeriSign, Inc., (NASDAQ: ABGX) Abgenix, Inc., (NASDAQ: ERICY) LM Ericsson Telephone Co. added to W.W. Rolling Stocks.
- M2 PRESSWIRE-7 April 2005-WillyWizard.com: Stock Watch: (NASDAQ: VRSN) VeriSign, Inc., (NASDAQ: ABGX) Abgenix, Inc., (NASDAQ: ERICY) LM Ericsson Telephone Co. added to W.W. Rolling StocksC1994-2005 M2 COMMUNICATIONS LTD RDATE:07042005 Stock Watch: (NASDAQ: VRSN) VeriSign, Inc., (NASDAQ: ABGX) Abgenix, Inc., (NASDAQ:...
- Research articles 2005-04-07
- Abgenix to Present at JP Morgan 23rd Annual Healthcare Conference
- FREMONT, Calif. -- Abgenix, Inc. (Nasdaq: ABGX) today announced that the company will present at the JP Morgan 23rd Annual Healthcare Conference in San Francisco on Thursday, January 13, 2005 at 10:30 a.m. PT, 1:30 p.m. ET. The presentation will be webcast live and may be accessed by visiting the...
- Research articles 2005-01-07
- Abgenix to Present at Needham & Company's Third Annual Biotechnology Conference
- Business Editors/Health/Medical Writers Needham & Company's Third Annual Biotechnology Conference FREMONT, Calif.--BUSINESS WIRE--June 14, 2004 Abgenix, Inc. (Nasdaq:ABGX) today announced that it will present at Needham & Company's Third Annual Biotechnology Conference on Thursday, June 17, 2004 at 6:30 a.m. PT, 9:30 a.m. ET. The presentation will...
- Research articles 2004-06-14
- Abgenix to Present at Goldman Sachs Twenty-Fifth Annual Global Healthcare Conference
- Business Editors/Health/Medical Writers Goldman Sachs 25th Annual Global Healthcare Conference FREMONT, Calif.--BUSINESS WIRE--June 3, 2004 Abgenix, Inc. (Nasdaq:ABGX) today announced that it will present at the Goldman Sachs 25th Annual Healthcare Conference on Thursday, June 10, 2004 at 7:40 a.m. PT, 10:40 a.m. ET. The presentation will...
- Research articles 2004-06-03
- Abgenix to Present at Banc of America Securities Healthcare Conference
- Business Editors/Health/Medical Writers Banc of America Securities Healthcare Conference FREMONT, Calif.--BUSINESS WIRE--March 20, 2003 Abgenix, Inc. (Nasdaq:ABGX) today announced that Raymond Withy, Ph.D., president and chief executive officer will present at the Banc of America Securities Healthcare Conference in Las Vegas on Wednesday, March 26, 2003 at...
- Research articles 2003-03-20
- Abgenix to Present At JP Morgan H&Q 21st Annual Healthcare Conference
- Business Editors FREMONT, Calif.--BUSINESS WIRE--Jan. 6, 2003 Abgenix, Inc. (Nasdaq:ABGX) today announced that it will present at the JP Morgan H&Q 21st Annual Healthcare Conference in San Francisco on Thursday, January 9, 2003 at 10:00am PST. The presentation will be webcast live and may be accessed by visiting...
- Research articles 2003-01-06
- Abgenix Announces Executive Promotions in Clinical Development
- Business Editors/Health & Medical Writers FREMONT, Calif.--BW HealthWire--Feb. 19, 2002 Abgenix, Inc. (Nasdaq:ABGX) announced today two senior promotions in its clinical development organization. Gisela M. Schwab, M.D. was promoted to chief medical officer, and Gregory M. Bell, M.D. was promoted to vice president, clinical development, inflammation. These promotions...
- Research articles 2002-02-19
- Stocks Activity Accelerates Following News.
- VANCOUVER, BRITISH COLUMBIA, NOVEMBER 6, 2001 Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was XO Communications, Inc. (NASDAQ: XOXO), trading over 12,600,000 shares after the Company announced that it has ...
- Research articles 2001-11-06
- Abgenix to Pay for Immgenics Acquisition With Cash Rather Than With Stock
- Business Editors/Health & Medical Writers FREMONT, Calif.--BW HealthWire--Feb. 23, 2001 Abgenix, Inc. (Nasdaq:ABGX) announced today that it intends to pay for its November 2000 acquisition of ImmGenics Pharmaceuticals, Inc., located in Vancouver, Canada, with approximately $77 million in cash, rather than with Abgenix common stock. Pursuant to the...
- Research articles 2001-02-23
- Silicon Valley Emerges as a Center for Germ Warfare Research.(Knight Ridder/Tribune Business News)
- Aug. 27--At a scientific conference two years ago, a Department of Defense investigator asked Geoff Davis whether his biopharmaceutical company would help the U.S. Army produce human antibodies to help counteract the deadly Ebola and Marburg viruses. The Pentagon suspected potentially hostile countries and terrorists were...
- Research articles 2000-08-27
Additional Resources
- Abgenix and Pfizer Add Second Antigen Target.(Pfizer Inc. and Abgenix Inc. announce a second antigen target )(Business Brief)(Product Announcement)
- PFIZER INC., a collaborative partner of Fremont, Calif-based Abgenix Inc., will develop a second antigen target using Abgenix's XenoMouse technology. Under the agreement between the companies, Abgenix will use its technology to generate human antib PFIZER INC., a collaborative partner of Fremont, Calif-based ...
- Research articles 1998-11-02
- Research and Markets: Gain Insight In To Abgenix Inc
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c50575) has announced the addition of "Abgenix Inc - Deals and Alliances Report" to their offering.
- Research articles 2007-02-16
- Abgenix to Receive Milestone Payment from Amgen for Advancement of Product Candidate into Clinical Trials; Eleventh XenoMouse Antibody Advances to the Clinical Phase
- FREMONT, Calif. -- Abgenix, Inc. (Nasdaq:ABGX) announced today that the company will receive a milestone payment from Amgen triggered by Amgen's advancement of an undisclosed antibody, created using Abgenix's proprietary XenoMouseR technology, into clinical trials. This is the eleventh antibody generated with Abgenix's technology to move into the clinic phase.
- Research articles 2005-01-13
- Abgenix to Present at UBS Global Life Sciences Conference
- FREMONT, Calif. -- Abgenix, Inc. (Nasdaq:ABGX) today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 27, 2004, at 9:00 a.m. ET, 6:00 a.m. PT. The presentation will be webcast live and may be accessed by visiting the Abgenix website at www.abgenix.com. A replay...
- Research articles 2004-09-20
- Japan Tobacco Inc. Announces Sale of Xenotech Interest
- Business Editors TOKYO--BUSINESS WIRE--Dec. 21, 1999 Japan Tobacco Inc. JT (TSE: 2914) today announced that Abgenix, Inc. Abgenix has agreed to buy the interest held by JT America in Xenotech Inc. and Xenotech, L.P. (together, Xenotech) for US $47 million. JT has accepted the offer with completion set...
- Research articles 1999-12-21
- << Previous
- page 1 of 1
- Next >>
